Navigating the Transformative Shift in the PBM Industry: Insights from The Bachan Group

Why this matters to you? Because 20-30% of your total healthcare costs come from Rx and this segment is growing faster than medical spend every year!

We are at a pivotal moment in the pharmacy benefit management (PBM) industry. Intense scrutiny from the media and government regulators is revealing the flaws in traditional PBM practices, validating the very principles The Bachan Group was founded on.

By partnering with The Bachan Group, you are not just witnessing this industry transformation; you are actively participating in it. Let's explore the recent developments and what they mean for you and your business.

Key Industry Developments

In recent weeks, there has been a surge in media coverage and regulatory actions that have raised important questions about the PBM industry. Here are some key stories that have been making headlines:

• The New York Times published an in-depth investigative piece on June 21st, shedding light on questionable PBM practices.
• The Wall Street Journal released several impactful articles, including: FTC to Sue Drug Managers Over Insulin Prices (July 10th) , How Drug Middlemen Keep Beating the System (July 10th) , Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says (July 9th) Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite (June 25th)
• An employer was sued earlier this year for breaching fiduciary duty by selecting a misaligned PBM, highlighted in a STAT op-ed on June 12th.
• The FTC's interim report on PBM malpractice was released on July 9th.
• Numerous articles have been published about lawsuits against PBMs.

These developments have led many employers to ask, "Are we being taken advantage of by our PBM?"

The Bachan Group: Your Partner in Transparency and Innovation

The "Big Three" PBMs—Optum Rx, CVS Caremark, and Express Scripts—owned by healthcare giants UnitedHealth, CVS/Aetna, and Cigna, respectively, have long dominated the market, often to the detriment of employers and patients.

The Bachan Group offers a modern alternative. Our business model, PBM partners & practices are fundamentally different from those legacy PBMs. By choosing us, you’ve aligned yourself with a transparent, client-focused approach that prioritizes your interests and challenges the status quo.

How The Bachan Group Sets Itself Apart

• Transparency: Unlike opaque legacy PBMs, The Bachan Group operates with full transparency when helping you select a PBM partner.
• 100% Pass-Through Model: We offer only 100% pass-through PBM models, passing all pharmacy spread and rebates directly to you.
• Cost-Based Approach: We prioritize finding the lowest cost drugs rather than focusing on the highest discounts.
• Universal Deal: We provide a universal deal to all clients, ensuring small groups are not overcharged to subsidize larger groups.
• Conflict-Free: Our model is free from conflicts of interest. Unlike legacy Brokers & PBMs, we do not own mail-order or specialty pharmacies.

Our approach culminates in a PBM consulting service that’s fully aligned with your interests. We’re dedicated to reducing your costs while ensuring your employees receive the high-quality healthcare they deserve.

Open Dialogue and Commitment to Excellence

The recent media coverage and regulatory scrutiny have sparked essential conversations about the PBM industry. We see this as an opportunity to further demonstrate our commitment to transparency and client satisfaction. Whether you have questions about the recent news, the PBM industry in general, or about The Bachan Group, we are here to provide clear, honest answers..

Thank you for being part of The Bachan Group community and for joining us in reshaping the future of pharmacy benefit management.

If you have any questions or would like to learn more about how The Bachan Group can support your business, don’t hesitate to get in touch. Let's continue to build a better, more transparent future together.